Osteoarthritis: Prognosis and emerging therapeutic approach for disease management.

Kumar, Amresh; Palit, Partha; Thomas, Sabu; Gupta, Gaurav; Ghosh, Parasar; Goswami, Rudra Prosad; Kumar Maity, Tapan; Dutta Choudhury, Manabendra

Kumar, Amresh; Palit, Partha; Thomas, Sabu; Gupta, Gaurav; Ghosh, Parasar; Goswami, Rudra Prosad; Kumar Maity, Tapan; Dutta Choudhury, Manabendra.

Afiliação

Kumar A; Department of Life Sciences and Bioinformatics, Assam University, Silchar, India.
Palit P; Department of Pharmaceutical Sciences, Assam University, Silchar, India.
Thomas S; Department of Chemical Sciences, Mahatma Gandhi University, Kottayam, India.
Gupta G; Department of Immunology, University of Manitoba, Winnipeg, Manitoba, Canada.
Ghosh P; Area of Biotechnology and Bioinformatics, NIIT University, Neemrana, Rajasthan, India.
Goswami RP; Department of Rheumatology, Institute of Post Graduate Medical Education &Research, Kolkata, India.
Kumar Maity T; Department of Rheumatology and Clinical Immunology, AIIMS, New Delhi, India.
Dutta Choudhury M; Department of Pharmaceutical Technology, Jadavpur University, Kolkata, India.

Drug Dev Res ; 82(1): 49-58, 2021 02.

Article em En | MEDLINE | ID: mdl-32931079

Assuntos

Osteoartrite/tratamento farmacológico; Animais; Cartilagem Articular/metabolismo; Humanos; Peptídeos e Proteínas de Sinalização Intercelular/metabolismo; Articulações/metabolismo; Osteoartrite/epidemiologia; Osteoartrite/etiologia; Osteoartrite/metabolismo; Prognóstico

Palavras-chave

CXCR4; DDR2; SDF-1; asporin; gut-microbiome; leptin; osteoarthritis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Osteoartrite Tipo de estudo: Etiology_studies / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google